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Background: Yindan Xinnaotong capsule has been used for treating cardio-cerebrovascular diseases for several
decades in China. Exercise training can protect against the development of atherosclerosis. The aim of the present
study is to evaluate the joint effect of YXC and exercise on atherosclerosis in rats.
Methods: A combined method involving low shear stress and a high-fat diet was used to establish the atherosclerosis
model in rats. Partial ligation of the left common carotid artery was performed, and then the rats were divided into 9
treatment groups according to a 3 × 3 factorial design with two factors and three levels for each factor, swimming of 0,
0.5, 1 h daily and YXC administration of 0, 1, 2 g/kg p.o. daily. Next the interventions of swimming and YXC were executed
for 8 weeks. After that, blood samples were collected to determine blood viscosity, plasma viscosity, haematocrit (HCT),
fibrinogen (FIB), blood lipid profile (including total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), triglyceride
(TG) and high-density lipoprotein-cholesterol (HDL-C)), nitric oxide (NO), 6-keto- prostaglandin (PG) F1α, endothelin (ET)
and thromboxane (TX) B2. The common carotid arteries of the rats were harvested to examine pathological changes, wall
thickness and circumference, and the expression of SM22αwas assayed via immune-histochemistry.
Results: The early pathological changes were observed. The joint effects of YXC and swimming showed significant
changes in the examined parameters: (1) decreases in plasma viscosity, blood viscosity and FIB; (2) increases in NO and
6-keto-PGF1α; (3) decreases in ET and TXB2; and (4) decreases in LDL-C and TG. The combination of 2 g/kg YXC and 1 h
of swimming led to synergistic decreases in LDL-C and TG. The interactive effect between YXC and swimming was
obvious in decreasing wall thickness. Swimming alone was able to up-regulate the expression of SM22α.
Conclusions: In conclusion, this study indicates that the combination of YXC and swimming may prevent atherosclerosis
through a synergistic effect between YXC and swimming in improving blood circulation, hemorheological parameters,
blood lipids levels and the vascular endothelium in rats. The vascular remodeling may be contributed to the prevention
effects on AS by up-regulating SM22α.
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Atherosclerosis (AS) is a pathological condition that under-
lies several important adverse vascular events such as an-
gina, myocardial infarction, strock, which are recognized as
leading causes of morbidity and mortality worldwide. The
World Health Organization (WHO) predicts that heart
diseases and stroke are becoming more deadly, a projected
combined death toll will reach 24 million by 2030 [1].
AS is a complex and multifactorial process. Although
the pathogenic role of lipid retention and inflammation
in AS is widely aware, shear stress–related events should
deserve more concerns. Caro and his co-workers [2,3]
showed that hemodynamic factors have been thought to
be highly relevant to AS [4-6]. Recent studies have found
that low shear stress (<4 dynes/cm2) might be involved
in the development of AS [7], but high shear stress
contributes to an anti-atherosclerotic effect [8].
Influence of turbulent blood flow on lesion develop-
ment of AS is closely associated with endothelium.
Eendothelial cells sense wall shear stress and transfer
this information to stimulate secretion of inflammatory
cytokine. If this inflammatory cytokine still exist, it will
result in proliferation and migration of vascular smooth
muscle cells and further remodeling of vascular [9-11]. A
large body of evidences have demonstrated that shear
stress within the physiological range elicit NO release in
cultured endothelial cells [12]. Grabowski showed that
shear stress could increase the levels of PGI2 in endo-
thelial cells [13].
In addition, other events such as endothelial dysfunc-
tion, inflammation, lipoprotein oxidation, retention and
aggregation [14-16] have been implicated in AS. Endo-
thelial dysfunction is considered as a first initiator in AS,
which is characterized by the decrease of nitric oxide
(NO), the increase of endothelin (ET) and alteration in
the production of prostanoids, which can provoke ath-
erosclerotic lesion formation [17-19]. Inflammation is
also necessary and sufficient to promote initiation and
development of AS. Some inflammatory makers includ-
ing C-reactive protein (CRP), interleukin-1β (IL-1β) and
interleukin-18 (IL-18) are regarded as the indicators of
AS development [20,21].
There are also many investigators considering suben-
dothelial retention of atherogenic lipoproteins as the key
pathogenic process in atherogenesis. Several lines of
evidence indicate that hyperlipidemia can lead to lesion
development in specific sites in the existence of predis-
posing stimuli, such as sheer stress. Following lipoprotein
retention caused by abundant atherogenic lipoproteins,
aggregation promptly occurs or may be part of the
retentive process. Once significant retention has oc-
curred, the early responses of AS, including lipoprotein
oxidation and cellular chemotaxis, accelerate AS lesion
development [16].Ross et al. had also proposed that atherosclerosis is
progressive disease characterized by the accumulation of
lipids and fibrous elements in the arterial walls and is
the primary cause of heart disease and stroke. In the
earliest stages of atherosclerosis, cholesterol accumulates
in several locations and bring about the formation of
foam cells, lead to growth of atherosclerotic lesion [22].
Some researchers agree that exercise can also help to pre-
vent AS, in addition to medication and dietary control [23].
Okabe Taka-aki [24] and Shimada et al. [25] showed that
swimming could suppress the development of AS plaques
in the carotid artery in apoE deficient mice, and this effect
occurs via the antioxidant action of the nitric oxide system.
Other scholars concluded that physical exercise can affect
local vascular and systemic inflammation in AS through de-
creasing inflammation and endothelial dysfunction [26].
Biomechanopharmacology by Fulong Liao [27] believes that
the joint effects of medication and biomechanical factors
(including flow shear stress) play an important role in pre-
venting AS. Yun You et al. [28] demonstrated that the com-
bination of an oral SL (SL, the Chinese abbreviation for
Radix Salviae miltiorrhizae and Andrographis paniculata)
extract with swimming inhibited inflammatory factors, im-
proved hemorheological parameters and lipid profile in rat
model of AS.
Traditional Chinese medicine (TCM) with the efficacy
of activating blood circulation and eliminating stasis
function is beneficial for cardio-and cerebrovascular dis-
eases in China [29]. Yindan Xinnaotong capsule (YXC) is
composed of Ginkgo biloba, Radix Salviae miltiorrhizae,
Gynostemma pentaphyllum, Erigeron breviscapus, Allium.
sativam L.var.Viviparum Regel, Panax notoginseng, Cra-
taegus pinnatifida Bge. and Borneolum syntheticum (the
ratio of each medicine was 50:50:30:30:40:20:40:1), and
indicates an anti-atherosclerotic effect in animal experi-
ments and clinical application, and the mechanism
may involve decreasing blood lipid concentrations, anti-
inflammatory or anti-coagulation properties, protecting
the vascular endothelium and improving microcirculation
[30-33]. However, the effects of YXC on vascular re-
modeling have been poorly described in the literature.
Exercise can protect against the development of AS
via regulating blood flow shear stress, and YXC showed
anti-atherosclerosis action, so this study was designed to
test the hypotheses that there may be some synergistic
or addictive effects between exercise and YXC in pre-
venting atherosclerosis. For the attempt, a factorial de-
sign of two factors, swimming and YXC, was employed.
Methods
Animal preparation and surgery protocol
Eighty male Sprague–Dawley rats (180–200 g) were pur-
chased from the experimental animal centre of the Chinese
People’s Liberation Army (PLA) Military Academy of
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were divided into nine interventional groups (n =8,
each) and one sham-operated group (n = 8). All animal
experiments were approved by the Laboratory Animal
Ethics Committee of the Institute of Basic Theory of
TCM, China Academy of Chinese Medical Sciences
(Beijing, China). All animals were handled in accordance
with international ethics requirements. The approve code
of Ethics Committee was SYXK (Jing) 2005–2008 and the
period of validity was from Aug, 2011 to Aug, 2015.
An animal model of early AS in rats was established
by ligation of the left common carotid artery (LCCA) to
induce vascular stenosis. Stenosis of the LCCA was
established by the method described by Fang Hua [34],
Shi Fang Ding [35] and Douglas Nam [36] with some
modifications. Briefly, after the rats were anaesthetised
using 10% chloral hydrate at 0.3 g/kg via intraperitoneal
injection, the surgical area was epilated and disinfected
with betadine. Then, a surgical incision was made at the
midline of the neck while the rats were in a supine pos-
ition, and the LCCA and external carotid artery bifur-
cation were carefully isolated, without damage to the
vessels or recurrent laryngeal nerve. A segment of suture
(5–0) was placed around the LCCA, and a sterile acu-
puncture needle with an outer diameter of 0.30 mm
(Wuxi Jiajian Medical Instrument Company, Wuxi
China) was placed under the suture parallel to the
LCCA. The needle was tied tightly together with the
LCCA using the suture at a distance of 1.5 cm from the
bifurcation. The needle was then quickly removed, and
the tied suture remained around the LCCA. Thus, the
inner diameter of the stenosed portion of the LCCA was
about 0.3 mm, and a LCCA stenosis was formed. Finally,
a single intramuscular injection of gentamicin sulphate
(3.5 ml/kg) was administered after the incision was
closed. The sham-operated group underwent the same
process without ligation of the artery.
The blood flow in the LCCA was monitored continu-
ously before and after surgery using a multichannel elec-
trophysiolograph, and the degree of stenosis was evaluated.
The stenosis rate was 46 ± 8%. After the carotid surgery,
the rats were placed in a cage and held at 28°C for 3 h,
then returned to the animal care room and fed a normal
diet. Thereafter, 6 × 105 IU · kg-1 vitamin D3 was intraperi-
toneally injected once per day for 2 days, except for the
sham-operated group.
YXC and exercise protocol
One week after surgery, the rats in the sham-operated
group were fed a normal diet, whereas the rats in the
other groups were fed a high-fat diet (1% cholesterol,
0.2% pig bile salts, 10% lard, 10% egg yolk powder, 78.8%
basal diet, which was purchased from Beijing Keao Xieli
Feed Co., LTD, China). The intervention describedbelow was applied for 8 weeks in all groups, except the
sham-operated group.
A factorial design involving two factors (swimming
and YXC) with three levels was adopted. The two factors
were swimming and YXC (Guizhou Bailing Group
Pharmaceutical Co., LTD, China. Lot number: 20120214).
The three levels of each factor were as follows: swimming
(no swimming, 0.5 hours per day, 1 hour per day) and
YXC capsule (no YXC, 1 g/kg per day, 2 g/kg per day).
Thus, nine groups were included in this 3 × 3 factorial
design.
A dose of 1 g/kg YXC in rats is approximately equal to
4.8 g per day for a human weighing 60 kg. So, 1 g/kg
YXC is so-called clinical equivalent dose in pharmacol-
ogy. The rats were orally administered a mixed liquid
consisting of YXC dissolved in purified water once daily
for 6 days per week.
The swimming duration was selected according to
Yun You [28] and Taka-aki Okabe [24]. The rats were
placed passively in a plastic swimming pool for the exer-
cise training (100 cm × 60 cm × 80 cm) at 35 ± 1°C. The
exercise duration was gradually increased with a step of
10 min on each subsequent day, starting from 10 min
and extending up to 30 min or 60 min, 5 days per week.
The whole swimming procession was supervised to en-
sure that every rat underwent the exercise training
during the period of swimming.
Hemorheological parameters and physicochemical
properties
All rats were fasted in the night of the last day of the 8th
week, and anaesthesia of 10% chloral hydrate at a dose
of 0.3 g/kg was administered via intraperitoneal injection
on the first day of the 9th week. Blood samples were col-
lected through the abdominal aorta. During this process,
three steps were carried out. The first 3 ml of blood was
collected using 3.8% sodium citrate (1:9) as an anti-
coagulant for hemorheological measurements, including
determination of blood viscosity, hematocrit (HCT),
plasma viscosity, fibrinogen (FIB) and thrombin time
(TT). The second, 2 ml sample was collected using 7.5%
disodium ethylene diamine tetraacetic acid (EDTA)
and aprotinin as anti-coagulants and spun at 3,000 rpm
for 15 min to determine the contents of ET, 6-keto-
PGF1α and thromboxane (TX) B2 in the serum. The
final, 3 ml whole-blood sample, without anti-coagulants,
was centrifuged at 3,000 rpm for 15 min, and the serum
was retained for determination of total cholesterol (TC),
triglyceride (TG), low-density lipoprotein-cholesterol
(LDL-C), high-density lipoprotein-cholesterol (HDL-C)
and NO.
Blood viscosity under shear rates of 10 s−1 and 200 s−1
at 37°C was tested with a blood viscometer (LBY-N6A,
Precil Co.). Plasma viscosity at 37°C was tested with a
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determined via the capillary centrifugation method. FIB
(Shanghai Sunbio Co., LTD., lot: 136042) and TT
(Shanghai Sunbio Co., LTD., lot: 121082) were deter-
mined using test kits.
Blood lipid profile was measured with an automatic
biochemistry analyser according to the manufacturer’s
protocol (GFD-800; Gaomi Caihong Analyser Co., Ltd.,
Shan-dong China), including TC, TG, LDL-C and HDL-C.
The four testing kits were all purchased from Beijing BHKT
Clinical Reagents Co., Ltd., China, with lot numbers of
20120115, 20130112, 20130401 and 20130507 accordingly.
The plasma concentrations of ET, 6-keto-PGF1α and
TXB2 were determined via radioimmunoassay using
commercially available kits. The three kits were obtained
from the Beijing Northern Bio-technology Research In-
stitute, with a same lot number of 20120620. The serum
concentration of NO was measured using a commer-
cially available kit according to the manufacturer’s in-
structions (Nanjing Jiancheng Bioengineering Institute,
lot: 20130624).
Evaluation of the vascular remodeling of the carotid
artery
After blood samples were collected from the abdominal
aorta, sections of the LCCA of 2 cm from the ligation
on either side were harvested, then fixed with 4% para-
formaldehyde and paraffin-embedded. Serial sections
were taken right and left separately near ligation. Carotid
artery sections (4 μm) were stained with hematoxylin
and eosin (HE), the images were obtained at × 200 mag-
nification and histopathological evaluations were per-
formed using 3–5 sections from different locations of
the carotid artery.
Vascular remodeling, including both structural and
functional remodeling, was evaluated. Pathological changes
were observed under an optical microscope (BX51, Olym-
pus Company, Tokyo, Japan), and images were captured
with an Olympus DP72 camera (Olympus Company,
Tokyo, Japan). The wall thickness (namely from the
innermost of intima to the outmost of media, and the
direction of measurement was perpendicular to vessel
wall) and vessel circumference were measured using
DP2-BSW image-analysis software (Olympus Company,
Tokyo, Japan). Three cross-sections from each aortic
section were used for the analysis of wall thickness and
vessel circumference, and the values were averaged.
Immunohistochemical analyses of SM22α expression
were performed. The primary antibody for these analyses
was the rabbit anti-rat SM22 alpha polyclonal antibody
(dilution 1:200; Abcam Ltd., Hong Kong), which was
used to distinguish the smooth muscle cells within the
lesions. The secondary antibody was streptavidin marked
by horse reddish peroxidise (Boster Bio co., LTD, Wuhan,China). Immunoreactivity was detected with the DAB
Kit (Boster Bio co., LTD, Wuhan, China), and the product
was identified by a brown colour. Phosphate buffer (PBS)
replaced the SM22 alpha antibody in the negative control,
and the other steps remained the same.
Following immunohistochemistry staining, an Olym-
pus imaging analysis system was employed to observe
the vascular walls and light microscope slices in each of
3–5 randomly selected high-power fields. The integrated
optical density (IOD) value of positive areas was mea-
sured with Image Pro Plus 6.0 imaging analysis software.
In our analysis, we used the relative level of positive ex-
pression, defined as the ratio of positive expression IOD
to the negative control IOD.
Statistical analysis
Statistical analysis was performed with SPSS version 11.5
(SPSS, Chicago, IL, USA). All data are expressed as the
mean ± SD. The GLM procedure was applied for a two-
way ANOVA to test for synergism. Comparisons be-
tween each pair of factor levels were analyzed using a




The values of plasma viscosity, blood viscosity at shear
rates of 10 s−1 and 200 s−1, FIB and HCT in the model
group were significantly higher than those in the sham-
operated rats and TT was lower (see Figure 1).
There were significant interactive effects between YXC
and swimming in decreasing plasma viscosity, blood vis-
cosities, FIB and HCT, suggesting YXC and swimming
could jointly improve hemorheological properties mark-
edly and the combination of the two factors could have
a synergistic effect (see Table 1).
Blood lipoprotein measurements
Compared to the sham-operated group, the levels of
serum TC, LDL-C and TG in the model group were sig-
nificantly higher (p < 0.05), while the levels of HDL-C
were significantly lower (p < 0.05) (see Figure 2A).
The significant interactive effects between YXC and
swimming on LDL-C and TG were found, indicating
that the combination of YXC and swimming could lead
to a marked decrease in blood lipoprotein level, while
no significant interaction effects between YXC and
swimming on TC and HDL-C were observed (see
Table 2). The effect of swimming on LDL-C was obvi-
ous, suggesting that exercise training is helpful for the
decrease of LDL-C instead of YXC. Treatment with
2 g/kg YXC exerted a decrease in TC and an increase
in HDL-C (see Table 2).
Figure 1 Bar graphs of hemorheological parameters compared
between model group and sham-operated group. All data are
expressed as the mean ± SD. Comparisons between sham group
and model group of factor levels were analyzed using Bonferon. A
value of P < 0.05 was considered statistically significant.
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First of all, the levels of NO in the model rats decreased
significantly (p < 0.05) and the levels of 6-keto-PGF1α
were reduced, whereas the levels of ET and TXB2 were
increased significantly (p < 0.05), compared to the rats in
the sham-operated group (see Figure 2B).
There still existed significant interactive effects be-
tween YXC and swimming in increasing NO and 6-keto-
PGF1α and decreasing ET and TXB2 (p < 0.05). YXC
made a greater contribution to increasing NO (F =
37.361, p = 0.000). Swimming showed a main effect on
decreasing TXB2 (F = 8.018, p = 0.001). The combinationof 0.5 h swimming with 1 g/kg YXC led to the decrease
of TXB2 with an increased 6-keto-PGF1α. The results
proved that treatment of YXC and swimming jointly
played a beneficial effect in improving endothelial func-
tions (see Table 3).
Histopathological assessment
The sham-operated group showed no histopathological
changes (Figure 3A). In the model group (Figure 3B),
the vessel wall appeared to be thicker, and lipids in the
intima were observed. The deposit of calcium, smooth
muscle hyperplasia of media, and elastic fiber injury
were also found. Based on the standard histological clas-
sification of AS lesions from the American Heart Associ-
ation [37], the animal model was in the initial stage of
AS. Histopathological findings from swimming groups
(Figure 3C,D) and YXC (Figure 3E,H) showed less
deposit of calcium and light intima injury. Only just a
little lipid was seen in treatment group 0.5 h swimming
(Figure 3C) and group 1 g/kg YXC (Figure 3E). The
changes of interaction between 1 g/kg YXC with 0.5 h
swimming (Figure 3F) and with 1 h swimming (Figure 3G)
in pathological was not found comparing with model
group. However a bit smooth muscle cell proliferation
and deposit of calcium were detected in the combined
groups of 2 g/kg YXC with 0.5 h swimming (Figure 3I)
and with 1 h swimming (Figure 3J). The other pathlogical
changes were not so obvious (see Figure 3). The above de-
scribed observation exhibited that there existed interactive
effects between 2 g/kg YXC and swimming in attenuating
pathology in the initial stage of AS.
Assessment of vascular construction remodeling
Compared to the sham-operated group, the wall thickness
in the model group was significantly greater (28.65 ±
5.66 μm vs. 19.40 ± 4.21 μm) (p < 0.05), the circumfer-
ence was significantly smaller (678 ± 73.86 μm vs. 758 ±
57.26 μm) (p < 0.05).
The significant interactive effects between YXC and
swimming were only obvious in decreasing the wall
thickness (F = 2.350, p = 0.047) (see Table 4).
Assessment of vascular functional remodeling
The result of immunohistochemistry staining showed
that compared with the sham group, there was min-
imal vascular staining (light yellow), and the relative
levels of SM22α were significantly decreased (5.27 ±
0.94 vs. 3.20 ± 0.87; p < 0.05) in the model group. When
different treatments were applied, SM22α was up regu-
lated to different degrees, and the staining was darker
(see Figure 4).
The main effect of swimming on SM22α protein level
was significant (F = 7.728, p = 0.001). YXC groups had
no influence on the relative levels of SM22α. The
Table 1 Hemorheological parameters of different treatment (mean ± SD) (n = 8, each)






FIB (g/L) HCT (%) TT (s)
0 0 1.09 ± 0.14 6.10 ± 0.96 3.41 ± 0.22 3.74 ± 0.78 45.46 ± 2.10 27.57 ± 1.83
0 0.5 1.00 ± 0.05 4.92 ± 0.77 3.02 ± 0.20 4.94 ± 1.20 41.23 ± 4.68 28.59 ± 2.24
0 1 0.99 ± 0.04 6.09 ± 0.73 3.20 ± 0.09 3.57 ± 0.67 45.44 ± 1.61 27.20 ± 0.99
1 0 1.03 ± 0.07 5.24 ± 0.97 3.05 ± 0.30 4.14 ± 1.03 41.35 ± 5.71 27.47 ± 0.85
1 0.5 1.04 ± 0.05 5.50 ± 0.60 3.12 ± 0.21 3.81 ± 0.60 42.32 ± 3.75 27.94 ± 1.67
1 1 1.01 ± 0.02 5.27 ± 0.89 3.05 ± 0.22 3.58 ± 0.20 41.24 ± 4.12 28.45 ± 1.77
2 0 0.98 ± 0.02 5.08 ± 0.87 2.95 ± 0.21 3.77 ± 0.29 40.66 ± 2.95 27.28 ± 1.41
2 0.5 1.00 ± 0.04 5.64 ± 0.67 3.18 ± 0.13 3.44 ± 0.27 44.03 ± 2.48 27.37 ± 1.09
2 1 1.01 ± 0.05 5.45 ± 0.84 3.18 ± 0.24 3.70 ± 0.74 42.55 ± 4.51 28.17 ± 1.01
Two-way ANOVA F P F P F P F P F P F P
YXC 2.365 0.101 1.496 0.237 3.153 0.049 2.413 0.098 2.720 0.073 0.168 0.845
Swimming 1.707 0.177 0.601 0.551 0.236 0.791 2.065 0.135 0.205 0.815 0.831 0.440
YXC × Swimming 3.276 0.016 3.192 0.018 5.263 0.001 4.052 0.005 2.554 0.047 0.855 0.495
All data are expressed as the mean ± SD. The GLM procedure was applied for a two-way ANOVA to test for synergism effect. Comparisons between each pair of
factor levels were analyzed using a Bonferon post hoc test. A value of P < 0.05 was considered statistically significant.
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creased relative levels of SM22α to different degrees,
revealing the interactive effects between YXC and
swimming in promoting vascular functional remodelling
(see Figure 5).Figure 2 Bar graphs of serum lipoproteins and endothelial
factors compared between model group and sham-operated
group. A) Comparison of serum lipoproteins between model group
and sham-operated group; B) Comparison of endothelial factors
between model group and sham-operated group. All data are
expressed as the mean ± SD. Comparisons between sham group
and model group of factor levels were analyzed using Bonferon. A
value of P < 0.05 was considered statistically significant.Discussion
Despite changes in lifestyle and the application of new
pharmacologic approach, cardiovascular diseases con-
tinuously are the principal cause of death. The lesions of
atherosclerosis represent a series of highly specific cellu-
lar and molecular responses that can be described not
only a lipid disorder, but also a highly characteristic
process of endothelial dysfunctions [22]. In fact, shear
stress-related events are closely related to the initiation
and development of AS [38]. Recent investigations show
that the maintenance of physiological laminar shear
stress is crucial for the regulation of blood flow, the in-
hibition of proliferation and inflammation of EC, the ab-
normal shear stress caused by disturbed or oscillatory
flows near arterial bifurcations, branch ostia and curva-
tures play a key role in the procession of AS. Cheng
et al. [39] demonstrated that lowered shear stress in-
duces atherosclerotic plaque, whereas increased shear
stress protects against atherosclerosis. Thus, whether the
regulation of shear stress will become a new therapeutic
target for treating AS is worth to be seriously consid-
ered. Fortunately, exercise, as a whole body periodic
acceleration and enhanced external conterpulsation, is
widely recognized as non-invasive methods to intervene
some cardiovascular diseases by elevating local or sys-
temic shear stress. The findings from Yun You [28] indi-
cated that the combined therapy of oral Chinese
medicine with swimming can inhibit inflammatory fac-
tors, improve hemorheological parameters and lipopro-
teins in a rat AS model induced by combination of low
shear stress resulted from partial ligation of common ca-
rotid artery with afterwards feeding of a hyperlipotic
diet. It may provide the insight into that-the modulation
Table 2 Blood lipid profile of different treatment (mean ± SD) (n = 8, each)
YXC (g/kg) Swimming (h) TC (mmol/L) LDL (mmol/L) TG (mmol/L) HDL (mmol/L)
0 0 2.56 ± 0.42 0.84 ± 0.15 1.49 ± 0.86 0.69 ± 0.18
0 0.5 2.39 ± 0.40 1.00 ± 0.33 0.95 ± 0.50 0.94 ± 0.52
0 1 2.39 ± 0.45 0.82 ± 0.22 0.45 ± 0.07 0.84 ± 0.16
1 0 2.10 ± 0.30 0.60 ± 0.23 0.62 ± 0.20 1.32 ± 0.30
1 0.5 2.65 ± 0.18 0.92 ± 0.16 0.78 ± 0.38 1.27 ± 0.31
1 1 2.38 ± 0.72 0.96 ± 0.28 1.24 ± 0.47 1.25 ± 0.32
2 0 2.07 ± 0.16 0.88 ± 0.04 0.76 ± 0.42 1.17 ± 0.19
2 0.5 2.31 ± 0.55 0.94 ± 0.31 0.68 ± 0.28 1.12 ± 0.33
2 1 1.77 ± 0.36 0.70 ± 0.10 0.47 ± 0.18 1.06 ± 0.20
Two-way ANOVA F P F P F P F P
YXC 4.098 0.022 0.419 0.660 2.387 0.098 10.628 0.000
Swimming 1.929 0.155 3.459 0.038 1.396 0.249 0.219 0.804
YXC × Swimming 1.782 0.146 3.950 0.028 5.480 0.001 0.566 0.689
All data are expressed as the mean ± SD. The GLM procedure was applied for a two-way ANOVA to test for synergism effect. Comparisons between each pair of
factor levels were analyzed using a Bonferon post hoc test. A value of P < 0.05 was considered statistically significant.
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“multi-targeted drug” against the some pathological
proneness like hypertension and AS.
In the present study, we employed an early AS model
in rats which was induced by a high-fat diet, partial
ligation of LCCA and vitamin D3 injection to investigate
the joint effect of combined Chinese medicine and exer-
cise training. The results showed that the combined
treatment of swimming and YXC significantly attenuated
the early pathological changes and improved hemorheo-
logical properties, the alleviation of lipoprotein retention
and endothelial injury by the combined intervention was
beneficial for the inhibition of AS.Table 3 Endothelial factors of different treatment (mean ± SD
YXC (g/kg) Swimming (h) NO (pg/ml) ET (p
0 0 16.80 ± 3.99 69.54
0 0.5 22.67 ± 4.28 60.32
0 1 24.38 ± 4.47 66.04
1 0 40.38 ± 7.61 73.21
1 0.5 32.00 ± 9.56 60.21
1 1 33.07 ± 8.07 65.16
2 0 39.62 ± 6.61 53.55
2 0.5 42.29 ± 12.83 62.75
2 1 36.19 ± 6.51 64.14
Two-way ANOVA F P F
YXC 37.361 0.000 3.642
Swimming 0.162 0.851 1.868
YXC × Swimming 3.142 0.020 4.418
All data are expressed as the mean ± SD. The GLM procedure was applied for a two
factor levels were analyzed using a Bonferon post hoc test. A value of P < 0.05 wasHemorheology play a critical role in initiation and de-
velopment of AS. The main factors of impacting hemor-
heology include blood viscosity, plasma viscosity, FIB,
HCT and so on. The changes of these factors directly in-
fluence the blood fluidity, viscosity and coagulation and
have become a risk event for AS. In the study, the joint ef-
fects of YXC and swimming indicated a significant de-
crease in plasma viscosity ((F = 3.276, p = 0.016), blood
viscosity at 10 s−1 (F = 3.192, p = 0.018) and 200 s−1 (F =
5.263, p = 0.001) FIB (F = 4.052, p = 0.005) and HCT (F =
2.554, p = 0.047). Specially, the combination of 2 g/kg
YXC and swimming exhibited more obvious effect. This
finding suggested that the interaction between 2 g/kg) (n = 8, each)
g/ml) TXB2 (pg/ml) 6-keto-PGF1α (pg/ml)
± 9.58 361.91 ± 56.38 57.08 ± 12.57
± 9.99 207.85 ± 66.03 84.86 ± 32.33
± 8.25 326.70 ± 155.64 78.76 ± 31.82
± 5.25 531.44 ± 126.99 65.84 ± 25.92
± 5.13 167.76 ± 86.16 63.27 ± 16.27
± 9.22 345.63 ± 139.01 69.27 ± 17.32
± 8.82 362.03 ± 76.92 105.91 ± 28.86
± 6.91 385.41 ± 157.32 85.35 ± 16.71
± 8.30 212.34 ± 90.98 45.26 ± 17.28
P F P F P
0.330 0.778 0.466 1.544 0.224
0.164 8.018 0.001 2.150 0.127
0.004 5.479 0.001 6.322 0.001
-way ANOVA to test for synergism effect. Comparisons between each pair of
considered statistically significant.
Figure 3 (See legend on next page.)
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Figure 3 Effect of different treatment on histopathological changes in LCCA sections by hematoxylin-eosin-stained (magnification,
×200). : deposit of calcium : deposit of lipid; : intima injury; : smooth muscle cells proliferation; : elastic fiber
injury. A) The sham group sample: The structure of artery including intimal layer, medial layer and adventitia was clear; B) The model group
sample (0 g/kg YXC × 0 h swimming): The arterial wall thickening was about 1/4 of A. Lipid in the intima increasing, deposit of calcium and
smooth muscle hyperplasia of media were seen. And elastic fiber was damaged; C) 0 g/kg YXC × 0.5 h swimming group sample: The focal artery
wall thickening, lipid and smooth muscle were seen; D) 0 g/kg YXC × 1 h swimming group sample: Obvious artery wall thickening was not seen,
and smooth muscle of media increased slightly; E) 1 g/kg YXC × 0 h swimming group sample: Focal artery wall thickening, lipid deposit, focal
deposit of calcium and slight smooth mucle cells were observed and less than group B; F) 1 g/kg YXC × 0.5 h swimming group sample and
G) 1 g/kg YXC × 1 h swimming group sample: There were not obvious changes compared with model group; H) 2 g/kg YXC × 0 h swimming
group sample: Smooth muscle of media increased slightly and focal deposit of calcium was seen; I) 2 g/kg YXC × 0.5 h swimming group sample:
Smooth muscle of media increased slightly and focal deposit of calcium was seen in media.; and J) 2 g/kg YXC× 1 h swimming group sample:
The focal endothelial cell injury and deposit of calcium were found. The abnormal changes can been seen in part of elastic fiber. The initial state
of atherosclerosis was found in the section (B) of the model rats. The pathological changes were suppressed to some degree by the combination
of 2 g/kg YXC and swimming (H-J), swimming alone (C, D) or 1 g/kg YXC alone (E).
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of AS by improving hemorheological parameters.
Many studies have shown that abnormal lipid metab-
olism is an important factor in the occurrence and de-
velopment of AS [40,41]. The increase of LDL-C
accompanied by a decrease in HDL-C is considered to
be a dangerous factor for evolution of AS [42]. In the
present study, the concentrations of HDL-C, LDL-C, TG
and TC were detected. Results indicated that there were
significant interactive effects between YXC and swim-
ming in LDL-C (F = 3.950, p = 0.028) and TG (F = 5.480,
p = 0.001), which suggested that the combination of
YXC and swimming played a significant role in improv-
ing blood lipids, and 2 g/kg YXC and 1 h of swimming
was the optimum combination,, through the effect of
YXC was slightly stronger than swimming in improving
the blood lipid profile.
Numerous pathophysiologic observations in humans and
animals led to the accormulation of the response-to-injuryTable 4 Structural remodeling measurement of different trea
YXC (g/kg) Swimming (h) Wall thickn
0 0 28.65 ± 5.66
0 0.5 22.91 ± 4.01
0 1 21.33 ± 2.55
1 0 25.46 ± 5.75
1 0.5 22.88 ± 4.14
1 1 22.61 ± 5.82
2 0 21.46 ± 2.81
2 0.5 22.67 ± 2.66




YXC × Swimming 2.350
All data are expressed as the mean ± SD. The GLM procedure was applied for a two
factor levels were analyzed using a Bonferon post hoc test. A value of P < 0.05 washypothesis of atherosclerosis, which initially proposed that
endothelial dysfunction was the first step in atherosclerosis.
And the levels of NO, ET, 6-keto-PGF1α and TXB2 are
closely associated with endothelial dysfunction, which has
been suggested to be early markers of AS. The decrease of
nitric oxide (NO), the increase of endothelin (ET) and alter-
ation in ratio of 6-keto-PGF1α, and TXB2 are the important
characters of endothelial dysfunction, which can promote
atherosclerotic lesion formation [43]. In the present study,
there existed a significant interaction between YXC and
swimming in increasing NO and 6-keto-PGF1α and de-
creasing ET and TXB2. The combined treatment of 2 g/kg
YXC with 0.5 h swimming and 2 g/kg YXC× 1 h swim-
ming) demonstrated obvious effects in increasing NO and
6-keto-PGF1α and decreasing ET and TXB2, swimming
alone had significant effect in decreasing TXB2 (F = 5.479,
p = 0.001). The demonstration suggested that the combin-
ation of YXC and swimming could retard AS development
by protecting the vascular endothelium.tment (mean ± SD) (n = 8, each)














-way ANOVA to test for synergism effect. Comparisons between each pair of
considered statistically significant.
Figure 4 Effect of different treatment on SM22α protein expression in LCCA sections by immunohistochemistrial staining
(magnification, ×200). A) The sham group sample; B) The model group sample; C) 0.5 h swimming group sample; D) 1 h swimming group
sample; E) 1 g/kg YXC group sample; F) 1 g/kg YXC and 0.5 h swimming group sample; G) 1 g/kg YXC and 1 h swimming group sample; H) 2 g/kg YXC
group sample; I) 2 g/kg YXC and 0.5 h swimming group sample; and J) 2 g/kg YXC and 1 h swimming group sample.
Wang et al. BMC Complementary and Alternative Medicine  (2015) 15:109 Page 10 of 13Evidences indicate that hypertrophy is the main type
of vascular remodeling in patients with AS [44]. The re-
modeling is characterized by an increase of intima-mediamembrane area within the blood vessel wall, and a narrow
of blood vessels in diameter, which was due to vascular
smooth muscle cell proliferation. In the present study,
Figure 5 Relative SM22α levels in different groups. The GLM procedure was applied for a two-way ANOVA to test for synergism effect.
Comparisons between each pair of factor levels were analyzed using a Bonferon post hoc test. A value of P< 0.05 was considered statistically significant.
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obviously greater than that in sham group, and the circum-
ference was clearly reduced. This result was consistent with
previously reported results [45]. The combination of swim-
ming and YXC also reduced the wall thickness significantly
(F = 2.350, p = 0.047). This result suggests that changes of
the wall thickness were contributed to inhibition of vascu-
lar remodeling by combination of YXC and swimming.
Phenotypic modulation of vascular smooth muscle
cells (VSMCs) plays a key role in vascular remodeling
diseases, such as AS, hypertension and restenosis, and is
a process common to all of the pathophysiological
changes. Recently, SM22α has been considered a marker
of contractile smooth muscle cells (SMCs) and vascular
remodeling, which is often used for the screening of
anti-vascular remodeling drug. Especially, SM22α modu-
lates vascular smooth muscle cell phenotype during de-
velopment of atherogenesis. In our study, SM22α was
examined in the LCCA via immunohistochemistry. We
found that the expression of SM22α decreased signifi-
cantly in the model group, which was consistent with
the results of Feil [46] and Wamhoff BR [47]. After
treatments with YXC and swimming, the expression of
SM22α increased to different degrees, and 0 h swim-
ming, 1 h swimming and 2 h swimming indicated a
more obvious influence. We speculated that swimming
may inhibit vascular remodeling by intervening in the
phenotypic transformation of mature SMCs and further
inhibit the development of atherosclerotic plaques.
Endothelial cells and smooth muscle cells are the main
units of the composition and function of vessels walls.
Vascular remodeling often occurs after endothelial injury
and leads to smooth muscle cell proliferation. When the
changed hemodynamic environment occurs, endothelial
cells can sense and transmit the stimulus, playing an im-
portant role, in conjunction with smooth muscle cells, in
the process of vascular remodeling through releasing a
series of substances [48]. L Wang et al. [49] found thatafter co-culturing endothelial cells (ECs) with smooth
muscle cells treated by low shear stress (LSS), ECs could
affect the proliferation and phenotypic transformation of
smooth muscle cells via IGF-1R, Akt phosphorylation
and Sirt2 expression. The present study showed that
swimming could markedly enhance the expression of
SM22α, a protein associated with the phenotypic trans-
formation of smooth muscle cells. According to L
Wang’s conclusion, the present study inferred that
swimming might suppress the phenotypic transform-
ation of smooth muscle cells by affecting endothelial
cells and inhibiting the process of vascular remodeling.
There is no doubt that the therapeutic interventions in
prevention and treatment of AS has gained popularity.
However, an important consideration is whether these
interventions effectively stop the procession of AS? The
application of Chinese medicines has a long history in
China, and the potential benefits in prevention and
treatment of cardiovascular diseases has been widely
accepted [50,51]. Currently, researchers found that dis-
turbed shear stress influences the site selectivity of
atherosclerotic plaque formation and its associated vessel
wall remodeling, whereas high shear stress might be like a
drug with biological reoponce and play a helpful role in
treating AS. Furthermore, biomechano-pharmacology, a
new borderline discipline [28] is forming between bio-
mechanics and pharmacology. The discipline will probably
consist of both the pharmacological intervention of signals
induced by biomechanical factors and the biomechanical
influence on pharmacokinetics and pharmacodynamics. In
fact, the impact of exercise on health has been recognized
since the ancient time. To date, it has become increasingly
clear that exercise, as a moderate-intensity physical ac-
tivity, can prevent cardiovascular disease because it can
elevate systematic blood circulation to promote blood shear
stress. Hence, the combined biological effects derived from
drugs and biomechanical forces may become a prospect
for preventing and treating AS.
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was used to investigate the joint effect of the combined
therapy in preventing and treating AS in rats. Our re-
sults demonstrated that this combination explored sig-
nificant interactive effects on the improvement of
hemorheological disorders, the pathological changes in
the early atherosclerosis and blood lipid profile. Further-
more, the ameliorated vascular endothelial function and
the increased vascular remodeling marker SM22α can be
contributed to one of mechanisms of the synergistic re-
action. The demonstration reveals that the intervention
of atherosclerosis by synergistic effects derived from ex-
ercise and a traditional Chinese medicine should be a
promising perspective. Therefore, to benefit from the
new discipline, going with a biomechanopharmacologi-
cally tailored exercise should be advocated, through the
coming into clinical use of biomechanopharmacology
still needs more time, greater efforts and popular aware-
ness from doctors and patients.
Conclusions
In conclusion, this study indicates that the combination
of YXC and swimming may prevent atherosclerosis
through a synergistic effects t between YXC (a medicinal
factor) and swimming (a physical exercise ) in improving
blood circulation, hemorheological parameters, blood
lipids levels and the vascular endothelium in rats. The
vascular remodeling may contributed to the prevention
effects on AS by up-regulating SM22α.
Abbreviations
6-keto-PGF1α: 6-keto- prostaglandin F1α; AS: Atherosclerosis; ET: Endothelin;
FIB: Fibrinogen; HCT: Haematocrit; HDL-C: High-density lipoprotein-
cholesterol; HE: Hematoxylin and eosin stain; LCCA: Left common carotid
artery; SM22α: Smooth muscle 22 alpha; TC: Total cholesterol;
TG: Triglyceride; TT: Thrombin time; TXB2: Thromboxane B2; YXC: Yindan
xinnao capsule.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JLW, LW, XJY, LLG and WD W carried out the whole studies, participated in
the statistical analysis and drafted the manuscript. HYX and YY helped to the
immunoassays. HJY participated in the design of the study and performed
the statistical analysis. L C conceived of the study, and participated in its
design. SR G participated in the pathological examination. RXL and FLL
participated in the design of the study and coordination and helped to draft
the manuscript. All authors read and approved the final manuscript.
Acknowledgements
This work was supported by the Chinese Drug Discovery Initiative Project
(No. 2012ZX09201201).
Author details
1China Academy of Chinese Medical Sciences, Institute of Chinese Material
Medical, Beijing, China. 2School of Traditional Chinese Medicine, Capital
Medical University, Beijing, China. 3Chinese Academy of Medical Sciences,
Institute of Medicinal Plant Development, Beijing, China. 4Guizhou Bailing
Group Pharmaceutical Co., Ltd, Guizhou, China.Received: 3 July 2014 Accepted: 10 March 2015References
1. No authors listed. WHO publishes definitive atlas on global heart disease
and stroke epidemic. Indian J Med Sci. 2004;58(9):405–6.
2. Caro CG, Fitz-Gerald JM, Schroter RC. Arterial wall shear and distribution of
early atheroma in man. Nature. 1969;223:1159–60.
3. Caro CG, Nerem RM. Transport of 14 C-4-cholesterol between serum and
wall in the perfused dog common carotid artery. Circ Res. 1973;32:187–205.
4. Jankowski P, Bilo G, Kawecka-Jaszcz K. The pulsatile component of blood
pressure: its role in the pathogenesis of atherosclerosis. Blood Press.
2007;16:238–45.
5. Helderman F, Segers D, de Crom R, Hierck BP, Poelmann RE, Evans PC, et al.
Effect of shear stress on vascular inflammation and plaque development.
Curr Opin Lipidol. 2007;18:527–33.
6. Siasos G, Tousoulis D, Siasou Z, Stefanadis C, Papavassiliou AG. Shear stress,
protein kinases and atherosclerosis. Curr Med Chem. 2007;14:20071567–72.
7. Gijsen F, van der Giessen A, van der Steen A, Wentzel J. Shear stress and
advanced atherosclerosis in human coronary arteries. J Biomech.
2013;46:240–7.
8. Stone PH, Coskun AU, Yeghiazarians Y, Kinlay S, Popma JJ, Kuntz RE, et al.
Prediction of sites of coronary atherosclerosis progression: in vivo profiling
of endothelial shear stress, lumen and outer vessel wall characteristics to
predict vascular behavior. Curr Opin Cardid. 2003;18:458–70.
9. Barbee KA, Davies PF, Lal R. Shear stress-induced reorganization of the
surface topography of living endothelial cells imaged by atomic force
microscopy. Circ Res. 1994;74:163–71.
10. Chiu JJ, Wang DL, Chien S, Skalak R, Usami S. Effects of disturbed flow on
endothelial cells. J Biomech Eng. 1998;120:2–8.
11. Shaaban AM, Duerinckx AJ. Wall shear stress and early atherosclerosis: a
review. AJR Am J Roentgenol. 2000;174:1657–65.
12. Ebong EE, Lopez-Quintero SV, Rizzo V, Spray DC, Tarbell JM. Shear-induced
endothelial NOS activation and remodeling via heparan sulfate, glypican-1,
and syndecan-1. Integr Biol (Camb). 2014;6(3):338–47.
13. Grabowski EF, Jaffe EA, Weksler BB. Prostacyclin production by culture
endothelial cells monolayers exposed to step increases in shear stress. J Lab
Clin Med. 1985;105:36–43.
14. Lowenstein C, Matsushita K. The acute phase response and atherosclerosis.
Drug Discov Today. 2004;1:17–22.
15. Lusis AJ. Atherosclerosis. Nature. 2000;407:233–41.
16. Williams KJ, Tabas I. The Response-to-Retention Hypothesis of Early
Atherogenesis. Arterioscler Thromb Vasc Biol. 1995;15(5):551–61.
17. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis.
Circulation. 2004;109(23 Suppl 1):III27–32.
18. Félétou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder
(The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol.
2006;291(3):H985–1002.
19. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction:a marker of
atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23:168–75.
20. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M,
et al. Markers of inflammation and cardiovascular disease: application to
clinical and public health practice: A statement for healthcare professionals
from the Centers for Disease Control and Prevention and the American
Heart Association. Circulation. 2003;107:499–511.
21. Kao ES, Wang CJ, Lin WL, Yin YF, Wang CP, Tseng TH. Anti-inflammatory Potential
of Flavonoid Contents from Dried. J Agric Food Chem. 2005;53:430–6.
22. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med.
1999;340:115–26.
23. Sasaki J. Exercise therapy for prevention of atherosclerosis. Nippon Rinsho.
2011;69:119.
24. Okabe TA, Shimada K, Hattori M, Murayama T, Yokode M, Kita T, et al.
Swimming reduces the severity of atherosclerosis in apolipoprotein E
deficient mice by antioxidant effects. Cardiovasc Res. 2007;74:537–45.
25. Shimada K, Kishimoto C, Okabe TA, Hattori M, Murayama T, Yokode M, et al.
Exercise training reduces severity of atherosclerosis in apolipoprotein E
knockout mice via nitric oxide. Circ J. 2007;71:1147–51.
26. Pinto A, Di Raimondo D, Tuttolomondo A, Buttà C, Milio G, Licata G. Effects
of Physical Exercise on Inflammatory Markers of Atherosclerosis. Curr Pharm
Des. 2012;18:4326–49.
Wang et al. BMC Complementary and Alternative Medicine  (2015) 15:109 Page 13 of 1327. Liao F, Li M, Han D, Cao J, Chen K. Biomechanopharmacology: a new
borderline discipline. Trends Pharmacol Sci. 2006;27:287–9.
28. You Y, Liu W, Li Y, Zhang Y, Li D, Li W, et al. Joint preventive effects of
swimming and Shenlian extract on rat atherosclerosis. Clin Hemorheol
Microcirc. 2011;47:187–98.
29. Liao F, Chen KJ. Biomechanopharmacology explanation for functions of
activating blood circulation. Chinese J Integrat Trad Western Med.
2006;26:869–70.
30. Zhang XP. Effects on carotid atherosclerotic plaques of Yindan Xinnaotong
capsule. Modern J Integrated Trad Chinese Western Med. 2012;21:3355–6.
31. Hu Y, Zhang J, Wang L, Cheng L. Regulation of Lipid Metabolism and
Vascular Endothelial Functionby Soft Capsule of Yindan Xinnaotong in
Hyperlipidemia Rat. Chinese J Exper Traditional Med Formulae.
2011;17:162–4.
32. Zhang J, Shi J, Wang L, Xia W, Huang J, Nie J, et al. Experimental study on
improving hyperlipidemia of Ying Dan Xin Nao Tong Capsulae Molles. Acta
Acad Med Zuny. 2010;33:4–6.
33. Zhang RP, Li YZ, Zhang JY, Gao CH, Feng J, Zhang JP. Effects of Yindan
Xinnaotong capsule on carotid atherosclerotic plaques and high-sensitivity
C-reactive protein in atherosclerosis rats. Chinese J Integrative Med Cardio-
Cerebrovascular Disease. 2013;11:57–8.
34. Hua F, Ma J, Li Y, Ha T, Xia Y, Kelley J, et al. The development of a novel
mouse model of transient global cerebral ischemia. Neurosci Lett.
2006;400:69–74.
35. Ding SF, Ni M, Liu XL, Qi LH, Zhang M, Liu CX, et al. A causal relationship
between shear stress and atherosclerotic lesions in apolipoprotein E
knockout mice assessed by ultrasound biomicroscopy. Am J Physiol Heart
Circ Physiol. 2010;298:2121–9.
36. Nam D, Ni CW, Rezvan A, Suo J, Budzyn K, Llanos A, et al. Partial carotid
ligation is a model of acutely induced disturbed flow, leading to rapid
endothelial dysfunction and atherosclerosis. Am J Physiol Heart Circ Physiol.
2009;297:1535–43.
37. Stary HC. Natural History and Histological Classification of Atherosclerotic
Lesions: An Update. Arterioscler Thromb Vasc Bio. 2000;20(5):1177–8.
38. Singh V, Tiwari RL, Dikshit M, Barthwal MK. Models to Study Atherosclerosis:
A Mechanistic Insight. Curr Vasc Pharmacol. 2009;7:75–109.
39. Cheng C, Tempel D, Haperen R, Baan A, Grosveld F, Daemen MJAP, et al.
Atherosclerotic lesion size and vulnerability are determined by patterns of
fluid shear stress. Circulation. 2006;113:2744–53.
40. Gotto Jr AM, Whitney E, Stein EA, Shapiro DR, Clearfield M, Weis S, et al.
Relation between baseline and on-treatment lipid parameters and first
acute major coronary events in the Air Force/Texas Coronary Atherosclerosis
Prevention Study (AFCAPS/TexCAPS). Circulation. 2000;101:477–84.
41. Rader DJ, Davidson MH, Caplan RJ, Pears JS. Lipid and apolipoprotein ratios:
association with coronary artery disease and effects of rosuvastatin
compared with atorvastatin, pravastatin, and simvastatin. Am J Cardiol.
2003;91:20c–3.
42. Mudd JO, Borlaug BA, Johnston PV, Kral BG, Rouf R, Blumenthal RS, et al.
Beyond low-density lipoprotein cholesterol: defining the role of low-density
lipoprotein heterogeneity in coronary artery disease. J Am Coll Cardiol.
2007;50:1735–41.
43. Poredos P, Jezovnik MK. Testing endothelial function and its clinical
relevance. J Atheroscler Thromb. 2013;20:1–8.
44. Hayoz D, Brunner HR. Remodeling of conduit arteries in hypertension:
special emphasis on the mechanical and metabolic consequences of
vascular hypertrophy. Blood Press Suppl. 1997;2:39–42.
45. de Korte CL, Hendrik HG, Hansen AFW, van der Steen W. Vascular
ultrasound for atherosclerosis imaging. Interface Focus. 2011;1:565–75.
46. Feil S, Hofmann F, Feil R. SM22alpha modulates vascular smooth muscle cell
phenotype during atherogenesis. Circ Res. 2004;94:863–5.
47. Wamhoff BR, Hoofnagle MH, Burns A, Sinha S, McDonald OG, Owens GK. A
G/C element mediates repression of the SM22alpha promoter within
phenotypically modulated smooth muscle cells in experimental
atherosclerosis. Circ Res. 2004;95:981–8.
48. Nerem RM, Harrison DG, Taylor WR, Alexander RW. Hemodynamics and
vascular endothelial biology. J Cardiovasc Pharmacol. 1993;21:s6–10.
49. Wang L, Han Y, Shen Y, Yan ZQ, Zhang P, Yao QP, et al. Endothelial Insulin-Like
Growth Factor-1 Modulates Proliferation and Phenotype of Smooth Muscle
Cells Induced by Low Shear Stress. Ann Biomed Eng.
2014;42:776–86.50. Cheng L, Pan GF, Sun XB, Huang YX, Peng YS, Zhou LY. Evaluation of
anxiolytic-like effect of aqueous extract of asparagus stem in mice. Evid
Based Complement Alternat Med. 2013; Epub 2013 Nov 20.
51. Cheng L, Meng XB, Lu S, Wang TT, Liu Y Sun GB, Sun XB: Evaluation of
hypoglycemic efficacy of Tangningtongluo formula, a traditional Chinese
Miao medicine, in two rodent animal models. J Diabetes Res. 2014;745419.
Epub ahead of print.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
